Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

866
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
866
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

610
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
610
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.8K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.8K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.1K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.1K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

578
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
578

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thermal Ablation with or without Liver Transplantation for Hepatocellular Carcinoma in Older Adults with Child-Pugh Class A Cirrhosis.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Selecting Pharmacologic Interventions for MASH.

Digestive diseases and sciences·2026
Same author

Refractory Ascites and the Alfapump.

Gastro hep advances·2026
Same author

Differentiating Immunoglobulin G4-Related Sclerosing Cholangitis From Primary Sclerosing Cholangitis: A Comprehensive Systematic Review and Meta-Analysis of Diagnostic Features.

The American journal of gastroenterology·2026
Same author

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Relationship between intestinal microbiota and muscle mass loss (sarcopenia) in older adults: a narrative review.

Gaceta medica de Mexico·2026
Same journal

Colorectal Cancer Outcomes Among Disaggregated Asian Subgroups: a 2006-2020 SEER Analysis.

Digestive diseases and sciences·2026
Same journal

Longitudinal Ulcer: Esophageal Tuberculosis Masquerading as Esophageal Crohn's Disease.

Digestive diseases and sciences·2026
Same journal

Effects of Abnormal Lipid Metabolism on Pancreatic Injury and Ferroptosis-Related Indicators in Rats with Severe Acute Pancreatitis.

Digestive diseases and sciences·2026
Same journal

Genetic Analysis of Isolated Hepatic Ductal Plate Malformation Reveals Novel Variants and Insights into Phenotypic Correlation.

Digestive diseases and sciences·2026
Same journal

Disease Burden of Early-Onset Pancreatic Cancer in Adults Aged 20-54 Years in Low- and Middle-Income Countries: A GBD 2023 Analysis.

Digestive diseases and sciences·2026
Same journal

Patient Perspectives of Intestinal Ultrasound in IBD: A Quantitative Evaluation of Satisfaction and Diagnostic Preference.

Digestive diseases and sciences·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.8K

Gastroenterologist's Guide to Assess for Alcohol Use.

Akshay Shetty1,2,3, Kabir Rahal4, Julio Meza5

  • 1Departments of Medicine, University of California at Los Angeles, Los Angeles, California, USA. akshayshetty@mednet.ucla.edu.

Digestive Diseases and Sciences
|April 16, 2026
PubMed
Summary
This summary is machine-generated.

Accurate alcohol use assessment is crucial for early diagnosis of alcohol-associated liver disease (ALD). Combining self-reporting tools with objective biomarkers improves detection and intervention for heavy alcohol use.

Keywords:
Alcohol biomarkersAlcohol use disorderAlcohol-associated liver diseasePETHPhosphatidylethanolScreening for alcohol use

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.8K
Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
08:45

Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis

Published on: November 8, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 18, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.8K
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.8K
Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
08:45

Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis

Published on: November 8, 2024

1.6K

Area of Science:

  • Hepatology
  • Addiction Medicine
  • Diagnostic Tools

Background:

  • Alcohol-associated liver disease (ALD) is a major cause of hospitalization and liver transplantation.
  • Delayed diagnosis of ALD due to asymptomatic heavy alcohol use presents a significant challenge.
  • Accurate alcohol consumption assessment is vital, especially with alcohol's impact on steatotic liver disease.

Purpose of the Study:

  • To review challenges in assessing alcohol use.
  • To highlight the importance of subjective alcohol assessment methods.
  • To examine objective tools available for quantifying alcohol consumption.

Main Methods:

  • PubMed database search for studies on ALD epidemiology, self-reporting tools, and biomarkers.
  • Review of relevant articles and references for inclusion in the analysis.
  • Focus on alcohol assessment in general and chronic liver disease patient populations.

Main Results:

  • Brief questionnaires are recommended for initial alcohol use screening in all patients.
  • Positive screening necessitates detailed alcohol assessments.
  • Patients with steatotic or chronic liver disease require thorough evaluation, including objective biomarkers to supplement self-reports.
  • Discrepancies between subjective and objective reports offer opportunities for patient engagement and treatment planning.

Conclusions:

  • Effective alcohol use assessment integrates both objective biomarkers and subjective self-reporting tools.
  • Early identification of harmful alcohol use and timely intervention can prevent severe ALD complications.
  • Referral to treatment is key to managing alcohol use and mitigating liver disease progression.